Drugs / CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07152236 | Aug 2025 → Mar 2026 | cancer | Guangzhou Bio-gene Technology Co., Ltd | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07152236 ↗ |
| Modality | Cell therapy | “CAR-T cell infusion” NCT07152236 ↗ |
| Route | Intravenous | “via intravenous infusion” NCT07152236 ↗ |